218 related articles for article (PubMed ID: 9802973)
1. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
[TBL] [Abstract][Full Text] [Related]
2. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
3. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
Screpanti V; Wallin RP; Ljunggren HG; Grandien A
J Immunol; 2001 Aug; 167(4):2068-73. PubMed ID: 11489989
[TBL] [Abstract][Full Text] [Related]
4. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
5. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
[TBL] [Abstract][Full Text] [Related]
6. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ
J Exp Med; 1999 Aug; 190(3):435-44. PubMed ID: 10430631
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
8. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
[TBL] [Abstract][Full Text] [Related]
9. Perforin dependence of natural killer cell-mediated tumor control in vivo.
van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
[TBL] [Abstract][Full Text] [Related]
10. Perforin is a major contributor to NK cell control of tumor metastasis.
Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
[TBL] [Abstract][Full Text] [Related]
11. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.
Johansson MH; Taylor MA; Jagodic M; Tus K; Schatzle JD; Wakeland EK; Bennett M
J Immunol; 2006 Dec; 177(11):7923-9. PubMed ID: 17114464
[TBL] [Abstract][Full Text] [Related]
12. Regulation of perforin-independent NK cell-mediated cytotoxicity.
Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
[TBL] [Abstract][Full Text] [Related]
13. Decreased tumor surveillance in perforin-deficient mice.
van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
15. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
16. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.
Pardo J; Balkow S; Anel A; Simon MM
Eur J Immunol; 2002 Oct; 32(10):2881-7. PubMed ID: 12355441
[TBL] [Abstract][Full Text] [Related]
17. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
[TBL] [Abstract][Full Text] [Related]
18. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
Kelly JM; Takeda K; Darcy PK; Yagita H; Smyth MJ
J Immunol; 2002 May; 168(9):4472-9. PubMed ID: 11970991
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ
Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585
[TBL] [Abstract][Full Text] [Related]
20. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
Smyth MJ; Snook MB
Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
